北京热景生物技术股份有限公司5%以上股东减持股份结果公告

Core Viewpoint - The major shareholder of Beijing Hotgen Biotech Co., Ltd. has completed a share reduction plan, selling a total of 1,796,980 shares, which is approximately 1.9383% of the company's total share capital, due to personal financial needs [2][4]. Group 1: Major Shareholder's Holdings - Before the reduction plan, the major shareholder, Zhou Xin, held 6,806,629 shares, accounting for 7.3420% of the company's total share capital [1]. Group 2: Reduction Plan Implementation - The reduction plan was disclosed on June 26, 2025, with a maximum intended reduction of 1,800,000 shares, representing up to 1.9416% of the total share capital [2]. - The actual reduction was completed by August 4, 2025, with Zhou Xin having sold 1,796,980 shares, achieving the planned reduction [2][4]. - The reduction plan was terminated early by the shareholder, indicating that the planned reduction was fully executed [4].